Mumps Virus Native Protein
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-62509
Key Product Details
Product Specifications
Description
Native mumps virus, Enders strain, cultured in BSC-1 cells.
Source: Virus
Amino Acid Sequence: UniProt P21277
Instructions For Use:
Product should be sonicated immediately before use to ensure the preparation is uniform. The product may be used in a variety of immunoassay formats or may be further purified to meet the requirements of a particular assay format.
Application Notes
Antigenic activity is 51.1% of internal reference batch
Protein / Peptide Type
Native Protein
Formulation, Preparation and Storage
NBP2-62509
| Preparation Method | Mumps virus, Enders strain, cultured in BSC-1 cells. Optimally infected cells are harvested, disrupted by sonication in culture medium and subjected to low speed centrifugation. The supernatant from the infected culture is concentrated by crossflow ultrafiltration. The antigen preparation is inactivated using gamma radiation, which primarily damages viral genetic material. |
| Formulation | Inactivated Mumps virus - liquid. Culture medium 1969B |
| Preservative | No Preservative |
| Concentration | Please see the vial label for concentration. If unlisted please contact technical services. |
| Shipping | The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Store at -70C. Avoid freeze-thaw cycles. |
Background: Mumps Virus
UniProt
Additional Mumps Virus Products
Product Specific Notices for Mumps Virus Native Protein
This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...